224 related articles for article (PubMed ID: 32093256)
1. TCR Repertoire Characterization for T Cells Expanded in Response to hRSV Infection in Mice Immunized with a Recombinant BCG Vaccine.
Rey-Jurado E; Bohmwald K; Correa HG; Kalergis AM
Viruses; 2020 Feb; 12(2):. PubMed ID: 32093256
[TBL] [Abstract][Full Text] [Related]
2. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM
Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474
[TBL] [Abstract][Full Text] [Related]
3. Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity.
Soto JA; Gálvez NMS; Rivera CA; Palavecino CE; Céspedes PF; Rey-Jurado E; Bueno SM; Kalergis AM
Front Immunol; 2018; 9():2875. PubMed ID: 30581437
[TBL] [Abstract][Full Text] [Related]
4. A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.
Díaz FE; Guerra-Maupome M; McDonald PO; Rivera-Pérez D; Kalergis AM; McGill JL
Front Immunol; 2021; 12():664212. PubMed ID: 33981309
[TBL] [Abstract][Full Text] [Related]
5. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.
Cautivo KM; Bueno SM; Cortes CM; Wozniak A; Riedel CA; Kalergis AM
J Immunol; 2010 Dec; 185(12):7633-45. PubMed ID: 21084664
[TBL] [Abstract][Full Text] [Related]
6. Immunization with a recombinant bacillus Calmette-Guerin strain confers protective Th1 immunity against the human metapneumovirus.
Palavecino CE; Céspedes PF; Gómez RS; Kalergis AM; Bueno SM
J Immunol; 2014 Jan; 192(1):214-23. PubMed ID: 24319265
[TBL] [Abstract][Full Text] [Related]
7. CD8+ T cell immunity against human respiratory syncytial virus.
Rossey I; Sedeyn K; De Baets S; Schepens B; Saelens X
Vaccine; 2014 Oct; 32(46):6130-7. PubMed ID: 25223272
[TBL] [Abstract][Full Text] [Related]
8. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.
Yang E; Lu Y; Xu Y; Liang Q; Wang C; Wang H; Shen H
Microb Pathog; 2014; 69-70():53-9. PubMed ID: 24726737
[TBL] [Abstract][Full Text] [Related]
9. A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.
Rey-Jurado E; Soto J; Gálvez N; Kalergis AM
Hum Vaccin Immunother; 2017 Sep; 13(9):2092-2097. PubMed ID: 28598702
[TBL] [Abstract][Full Text] [Related]
10. Role for Gr-1+ cells in the control of high-dose Mycobacterium bovis recombinant BCG.
Panas MW; Letvin NL
Clin Vaccine Immunol; 2014 Aug; 21(8):1120-7. PubMed ID: 24920602
[TBL] [Abstract][Full Text] [Related]
11. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults.
Pacheco GA; Andrade CA; Gálvez NMS; Vázquez Y; Rodríguez-Guilarte L; Abarca K; González PA; Bueno SM; Kalergis AM
Front Immunol; 2023; 14():1215893. PubMed ID: 37533867
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of recombinant BCG-based vaccine expressing the 22 kDa of serine repeat antigen (SE22) of Plasmodium falciparum.
Teo WH; Nurul AA; Norazmi MN
Trop Biomed; 2012 Jun; 29(2):239-53. PubMed ID: 22735846
[TBL] [Abstract][Full Text] [Related]
14. Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8
Lee JY; Chang J
J Microbiol; 2017 Nov; 55(11):900-908. PubMed ID: 29076066
[TBL] [Abstract][Full Text] [Related]
15. Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells.
Céspedes PF; Bueno SM; Ramírez BA; Gomez RS; Riquelme SA; Palavecino CE; Mackern-Oberti JP; Mora JE; Depoil D; Sacristán C; Cammer M; Creneguy A; Nguyen TH; Riedel CA; Dustin ML; Kalergis AM
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):E3214-23. PubMed ID: 25056968
[TBL] [Abstract][Full Text] [Related]
16. A Bivalent Recombinant
Kanno AI; Goulart C; Leite LCC; Pagliarone AC; Nascimento IP
Biomed Res Int; 2019; 2019():9630793. PubMed ID: 30941374
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
Deng YH; He HY; Zhang BS
J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
[TBL] [Abstract][Full Text] [Related]
18. Naked DNA immunization with full-length attachment gene of human respiratory syncytial virus induces safe and protective immune response.
Hamad ME; Amer HM; Farrag MA; Osman AH; Almajhdi FN
Acta Virol; 2018; 62(2):137-146. PubMed ID: 29895154
[TBL] [Abstract][Full Text] [Related]
19. More vaccine efficacy studies on the recombinant Bacille Calmette-Guerin co-expressing Ag85B, Mpt64 and Mtb8.4.
Qie YQ; Wang JL; Liu W; Shen H; Chen JZ; Zhu BD; Xu Y; Zhang XL; Wang HH
Scand J Immunol; 2009 Apr; 69(4):342-50. PubMed ID: 19284499
[TBL] [Abstract][Full Text] [Related]
20. Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency.
Farrag MA; Amer HM; Öhlschläger P; Hamad ME; Almajhdi FN
Hum Vaccin Immunother; 2017 Jul; 13(7):1586-1597. PubMed ID: 28272978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
